Aimin Li

2.4k total citations · 1 hit paper
33 papers, 1.6k citations indexed

About

Aimin Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Aimin Li has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 13 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Aimin Li's work include Ubiquitin and proteasome pathways (9 papers), Cancer-related molecular mechanisms research (7 papers) and RNA modifications and cancer (6 papers). Aimin Li is often cited by papers focused on Ubiquitin and proteasome pathways (9 papers), Cancer-related molecular mechanisms research (7 papers) and RNA modifications and cancer (6 papers). Aimin Li collaborates with scholars based in China, United States and Macao. Aimin Li's co-authors include Lea T. Grinberg, Louise C. Serpell, Timothy M. Miller, Hilda Mirbaha, Scarlett J. Barker, Sarah L. DeVos, William W. Seeley, Sarah K. Kaufman, Julian R. Thorpe and Marc I. Diamond and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Neuron.

In The Last Decade

Aimin Li

32 papers receiving 1.6k citations

Hit Papers

Distinct Tau Prion Strains Propagate in Cells and Mice an... 2014 2026 2018 2022 2014 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aimin Li China 18 1.0k 563 283 259 188 33 1.6k
Alexandra Szalad United States 20 750 0.7× 295 0.5× 311 1.1× 397 1.5× 239 1.3× 27 1.5k
Yuh‐Jin Liang Taiwan 24 877 0.9× 505 0.9× 105 0.4× 129 0.5× 126 0.7× 40 1.5k
Jee Young Sung South Korea 19 888 0.9× 316 0.6× 133 0.5× 299 1.2× 391 2.1× 39 1.8k
Gillian M. Borthwick United Kingdom 19 1.1k 1.1× 237 0.4× 93 0.3× 205 0.8× 160 0.9× 28 1.8k
Bénédicte Foveau Canada 18 850 0.8× 205 0.4× 209 0.7× 90 0.3× 144 0.8× 25 1.3k
Jayne Marasa United States 18 881 0.9× 529 0.9× 229 0.8× 216 0.8× 331 1.8× 26 1.7k
Peter K. Harris United States 14 620 0.6× 307 0.5× 75 0.3× 239 0.9× 118 0.6× 33 1.3k
Zhiyuan Zhu China 19 554 0.5× 161 0.3× 154 0.5× 340 1.3× 108 0.6× 46 1.2k
Anna Jurewicz Poland 18 638 0.6× 223 0.4× 210 0.7× 172 0.7× 118 0.6× 32 1.5k
Anja Apel Germany 12 569 0.6× 196 0.3× 99 0.3× 177 0.7× 89 0.5× 17 1.3k

Countries citing papers authored by Aimin Li

Since Specialization
Citations

This map shows the geographic impact of Aimin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aimin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aimin Li more than expected).

Fields of papers citing papers by Aimin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aimin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aimin Li. The network helps show where Aimin Li may publish in the future.

Co-authorship network of co-authors of Aimin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Aimin Li. A scholar is included among the top collaborators of Aimin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aimin Li. Aimin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Yilin, Yongfeng Liu, YiJiang Song, et al.. (2025). ARID1A loss enhances sensitivity to c-MET inhibition by dual targeting of GPX4 and iron homeostasis, inducing ferroptosis. Cell Death and Differentiation. 32(11). 2009–2021. 3 indexed citations
2.
Yang, Ping, Yidong Chen, Xiaodong Huang, et al.. (2025). Long non-coding RNA-MIR181A1HG acts as an oncogene and contributes to invasion and metastasis in gastric cancer. Oncogene. 44(20). 1517–1529. 3 indexed citations
3.
Hong, Linjie, Ping Yang, Luyu Zhang, et al.. (2023). The VAX2-LINC01189-hnRNPF signaling axis regulates cell invasion and migration in gastric cancer. Cell Death Discovery. 9(1). 387–387. 5 indexed citations
4.
Zhang, Keqiang, Ting Sun, Wendong Li, et al.. (2023). Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells. Cell Communication and Signaling. 21(1). 319–319. 7 indexed citations
5.
Guo, Linlin, Atish Mohanty, Sharad S. Singhal, et al.. (2023). Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors. iScience. 26(8). 107302–107302. 16 indexed citations
6.
Li, Jiaying, Xuehua Liu, Linjie Hong, et al.. (2023). The HOXD9-mediated PAXIP1-AS1 regulates gastric cancer progression through PABPC1/PAK1 modulation. Cell Death and Disease. 14(5). 341–341. 12 indexed citations
7.
Chen, Lu, Yiwen Li, Bing Huang, et al.. (2023). METTL14-dependent maturation of pri-miR-17 regulates mitochondrial homeostasis and induces chemoresistance in colorectal cancer. Cell Death and Disease. 14(2). 148–148. 38 indexed citations
8.
Li, Yue, Aimin Li, Qiang Zhang, et al.. (2022). Endoscopic resection via antral submucosal tunneling for en bloc removal of tumors in the duodenal bulb. Digestive Endoscopy. 34(5). 1063–1068.
9.
Han, Lu, Xin Lin, Qun Yan, et al.. (2022). PBLD inhibits angiogenesis via impeding VEGF/VEGFR2-mediated microenvironmental cross-talk between HCC cells and endothelial cells. Oncogene. 41(13). 1851–1865. 37 indexed citations
10.
Zhang, Haonan, Chengcheng He, Yuxin Fang, et al.. (2022). DDX39B contributes to the proliferation of colorectal cancer through direct binding to CDK6/CCND1. Cell Death Discovery. 8(1). 30–30. 26 indexed citations
11.
Sun, Ting, Keqiang Zhang, Wendong Li, et al.. (2022). Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression. Cell Communication and Signaling. 20(1). 147–147. 17 indexed citations
12.
Liu, Yongfeng, Changjie Wu, Chun-Cai Gu, et al.. (2021). Tumor-suppressive function of EZH2 is through inhibiting glutaminase. Cell Death and Disease. 12(11). 975–975. 12 indexed citations
13.
Dai, Weiyu, Jing Wang, Zhi Wang, et al.. (2021). Comprehensive Analysis of the Prognostic Values of the TRIM Family in Hepatocellular Carcinoma. Frontiers in Oncology. 11. 767644–767644. 27 indexed citations
14.
Wu, Xiaosheng, Hao Wang, Jing Wang, et al.. (2021). USP3 promotes gastric cancer progression and metastasis by deubiquitination-dependent COL9A3/COL6A5 stabilisation. Cell Death and Disease. 13(1). 10–10. 33 indexed citations
15.
16.
Lin, Xian, Aimin Li, Yonghao Li, et al.. (2020). Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma. Signal Transduction and Targeted Therapy. 5(1). 13–13. 142 indexed citations
17.
Cai, Jianqun, Xinmei Zhao, Zelong Han, et al.. (2019). Standing‐type magnetically guided capsule endoscopy versus gastroscopy for gastric examination: multicenter blinded comparative trial. Digestive Endoscopy. 32(4). 557–564. 21 indexed citations
18.
Wu, Xiaosheng, Mengwei Liu, Jing Wang, et al.. (2019). Ubiquitin-specific protease 3 promotes cell migration and invasion by interacting with and deubiquitinating SUZ12 in gastric cancer. Journal of Experimental & Clinical Cancer Research. 38(1). 277–277. 47 indexed citations
19.
Sanders, David W., Sarah K. Kaufman, Sarah L. DeVos, et al.. (2014). Distinct Tau Prion Strains Propagate in Cells and Mice and Define Different Tauopathies. Neuron. 82(6). 1271–1288. 720 indexed citations breakdown →
20.
Tiozzo, Caterina, Gianni Carraro, Denise Al Alam, et al.. (2012). Mesodermal Pten inactivation leads to alveolar capillary dysplasia-like phenotype. Journal of Clinical Investigation. 122(11). 3862–3872. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026